Akebia Therapeutics (AKBA) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

AKBA is expected to report earnings to rise 50.00% to -5 cents per share on November 07

Akebia Therapeutics AKBA Stock Earnings Reports

Q3'24

Est.

$-0.06

Q2'24

Beat

by $0.03

Q1'24

Missed

by $0.02

Q4'23

Beat

by $0.04

Q3'23

Est.

$-0.08

The last earnings report on August 08 showed earnings per share of -3 cents, beating the estimate of -7 cents. With 1.70M shares outstanding, the current market capitalization sits at 283.89M.

View a ticker or compare two or three

Compare

AKBA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For AKBA
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of drugs for the treatment of anemia and vascular diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

245 First Street

Phone

+1 617 871-2098

Employees

167

Web

https://www.akebia.com